Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

NCT03755739 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Hepatocarcinoma
Lung Cancer
Melanoma
Renal Cancer
Head and Neck Cancer
Pancreas Cancer
Ovarian Cancer
Colo-rectal Cancer
Cervical Cancer
Breast Cancer

Interventions

DRUG: Checkpoint inhibitor (CPI) such as Pembrolizumab plus chemotherapy

Sponsor

Second Affiliated Hospital of Guangzhou Medical University